Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Draper

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
Microbial Biotechnology|February 26, 2013
Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activityDes Field, Evelyn M Molloy, Catalin Iancu, et al.
Critical Care Medicine|January 1, 1996
Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study GroupW A Knaus, F E Harrell, J F LaBrecque, et al.
Microbiome|December 12, 2018
Long-term colonisation with donor bacteriophages following successful faecal microbial transplantationL A Draper, F J Ryan, M K Smith, et al.
Journal of Lipid Research|March 23, 2023
Cholesterol synthesis enzyme SC4MOL is fine-tuned by sterols and targeted for degradation by the E3 ligase MARCHF6Lydia Qian, Nicola A Scott, Isabelle M Capell-Hattam, et al.
Microbial Biotechnology|January 25, 2011
Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147Lucy H Deegan, Srinivas Suda, Elaine M Lawton, et al.
Plos Pathogens|September 13, 2008
Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenesPaul D Cotter, Lorraine A Draper, Elaine M Lawton, et al.
Medical Care|May 1, 1994
The performance of intensive care units: does good management make a difference?S M Shortell, J E Zimmerman, D M Rousseau, et al.
Plant Disease|February 14, 2019
Integrated Management Strategies for Phytophthora sojae Combining Host Resistance and Seed TreatmentsA E Dorrance, A E Robertson, S Cianzo, et al.
Critical Care Medicine|October 1, 1993
Value and cost of teaching hospitals: a prospective, multicenter, inception cohort studyJ E Zimmerman, S M Shortell, W A Knaus, et al.
Gut Microbes|March 30, 2023
Temperate bacteriophages infecting the mucin-degrading bacterium <i>Ruminococcus gnavus</i> from the human gutColin Buttimer, Ekaterina V Khokhlova, Lisa Stein, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
Microbial Biotechnology|February 26, 2013
Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activityDes Field, Evelyn M Molloy, Catalin Iancu, et al.
Critical Care Medicine|January 1, 1996
Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study GroupW A Knaus, F E Harrell, J F LaBrecque, et al.
Microbiome|December 12, 2018
Long-term colonisation with donor bacteriophages following successful faecal microbial transplantationL A Draper, F J Ryan, M K Smith, et al.
Journal of Lipid Research|March 23, 2023
Cholesterol synthesis enzyme SC4MOL is fine-tuned by sterols and targeted for degradation by the E3 ligase MARCHF6Lydia Qian, Nicola A Scott, Isabelle M Capell-Hattam, et al.
Microbial Biotechnology|January 25, 2011
Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147Lucy H Deegan, Srinivas Suda, Elaine M Lawton, et al.
Plos Pathogens|September 13, 2008
Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I Listeria monocytogenesPaul D Cotter, Lorraine A Draper, Elaine M Lawton, et al.
Medical Care|May 1, 1994
The performance of intensive care units: does good management make a difference?S M Shortell, J E Zimmerman, D M Rousseau, et al.
Plant Disease|February 14, 2019
Integrated Management Strategies for Phytophthora sojae Combining Host Resistance and Seed TreatmentsA E Dorrance, A E Robertson, S Cianzo, et al.
Critical Care Medicine|October 1, 1993
Value and cost of teaching hospitals: a prospective, multicenter, inception cohort studyJ E Zimmerman, S M Shortell, W A Knaus, et al.
Gut Microbes|March 30, 2023
Temperate bacteriophages infecting the mucin-degrading bacterium <i>Ruminococcus gnavus</i> from the human gutColin Buttimer, Ekaterina V Khokhlova, Lisa Stein, et al.
Pageof 21